(Q37459829)

20 August 2017

1 reference

title

Gram-positive toxic shock syndromes (English)

1 reference

20 August 2017

main subject

gram-positive bacteria

0 references

author name string

Emma Lappin

series ordinal

1

1 reference

20 August 2017

Andrew J Ferguson

series ordinal

2

1 reference

20 August 2017

publication date

1 May 2009

1 reference

Lancet Infectious Diseases

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

281-290

1 reference

The epidemiology of sepsis in the United States from 1979 through 2000

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Toxic-shock syndrome associated with phage-group-I Staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Toxic shock syndrome in the United States: surveillance update, 1979 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Active surveillance for toxic shock syndrome in the United States, 1986.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Recognition and management of Staphylococcus aureus toxin-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Epidemiology of severe Streptococcus pyogenes disease in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigens: microbial agents that corrupt immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Streptococcus pyogenes: Insight into the function of the streptococcal superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The staphylococcal enterotoxins and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Cutting edge: Evidence of direct TCR alpha-chain interaction with superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Selective expansion of T cells expressing V beta 2 in toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Diagnostic value of Vbeta2-positive T-cell expansion in toxic shock syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigens: mechanism of T-cell stimulation and role in immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Toxic shock syndrome and bacterial superantigens: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Endogenous superantigens shape response to exogenous superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

NF-kappa B activation as a pathological mechanism of septic shock and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

TCR recognition of peptide/MHC class II complexes and superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The bacterial superantigen and superantigen-like proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

On the pathogenesis of toxic shock syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Streptococcal M protein: a multipotent and powerful inducer of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Streptococcal superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The immunology of sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Host-pathogen interactions in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

1. Overview of the human immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The function and biological role of toll-like receptors in infectious diseases: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Toll-like receptors in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Increased surface toll-like receptor 2 expression in superantigen shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Progress toward Characterization of the Group A Streptococcus Metagenome: Complete Genome Sequence of a Macrolide‐Resistant Serotype M6 Strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigen-like gene(s) in human pathogenicStreptococcus dysgalactiae, subsp.equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speGdys)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Superantigen genes in group A streptococcal isolates and their relationship with emm types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Sexual dimorphism in innate immune responses to infectious organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Streptococcal toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Onset of streptococcal toxic shock syndrome is accelerated by bruising in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Managing toxic shock syndrome with antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Increasing telithromycin resistance among Streptococcus pyogenes in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Beyond MRSA: the growing menace of hVISA and VISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Gamma-globulin inhibits superantigen-induced lymphocyte proliferation and cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

Different Preparations of Intravenous Immunoglobulin Vary in Their Efficacy to Neutralize Streptococcal Superantigens: Implications for Treatment of Streptococcal Toxic Shock Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970066-0

7 January 2021

10.1016/S1473-3099(09)70066-0

Identifiers

DOI

1 reference

20 August 2017

1 reference